News and Events

News

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine i...

December 3rd, 2018

LUGANO, Switzerland and San Diego, USA, December 3, 2018: Helsinn Group, a Swiss pharmaceutical group focused on building quality cancer care products...

Read article

Helsinn and Mundipharma China Pharmaceutical announce tha approval of ALOXI®IV b...

December 3rd, 2018

Approval by the National Medical Products Administration (NMPA) brings ALOXI® to a large new patient population ALOXI® is a globally approved  anti-em...

Read article

ONO Submits an Application for Manufacturing and Marketing Approval of Anamoreli...

November 27th, 2018

Ono Pharmaceutical Co., Ltd. (Osaka, Japan, President and Representative Director: Gyo Sagara; “ONO”) announced today that ONO has submitted in Japan ...

Read article

Helsinn and Lyfebulb Announce Partnership for Second Annual Patient-Driven Innov...

November 27th, 2018

The award will be presented to the Patient Entrepreneur demonstrating outstanding science and potential to bring their idea to the market for cancer p...

Read article

Events

EADO

  • 6th November 2018 - 9th November 2018
  • Barcelona
  • Booth 8
Full event info

ESMO

  • 19th October 2018 - 23rd October 2018
  • Munich
  • Booth 222
Full event info

EORTC

  • 27th September 2018 - 29th September 2018
  • St. Gallen
Full event info